A34V_human-BCHE

General

Gene Locus : human-BCHE

Mode of mutation : Natural mutant

Disease :

Summary : Expression atypical silent phenotype Delacour_2014_Biochem.Pharmacol_92_476

AAA Change :

Allelic Variant :

Risk Factor :

Inhibitor :

Structure :

Disease by interaction :

Interact Gene Locus :

Xenobiotic sensitivity : Defect in Suxamethonium hydrolysis

Modification : Expression || Silent variant Natural mutation

Torpedo_number : 36

Kinetic Parameter : No kinetic parameter

News : OCTOBER-01-2014

Comment : p.A34V Ala34Val c.185C>T (p.A62V Ala62Val in primary sequence with 28 amino-acids signal peptide) in a compound heterozygote with D70G prolonged neuromuscular block after administration of suxamethonium or mivacurium. Daughter of the proband simple heterozygote had normal BChE activity

References (1)

Title : Characterization of a novel butyrylcholinesterase point mutation (p.Ala34Val), silent with mivacurium - Delacour_2014_Biochem.Pharmacol_92_476
Author(s) : Delacour H , Lushchekina SV , Mabboux I , Ceppa F , Masson P , Schopfer LM , Lockridge O
Ref : Biochemical Pharmacology , 92 :476 , 2014
Abstract : Delacour_2014_Biochem.Pharmacol_92_476
ESTHER : Delacour_2014_Biochem.Pharmacol_92_476
PubMedSearch : Delacour_2014_Biochem.Pharmacol_92_476
PubMedID: 25264279